By Heather Blumenthal Immunotherapy has become widely accepted, both in research and in practice, as a powerful tool for treating many kinds of cancer. Indeed, it’s often called the “fourth pillar” of cancer treatment, after surgery, chemotherapy and radiation. Dr. Douglas Mahoney, an associate professor at the University of Calgary and translational scientist at… Read more »
Category: News
Where Are They Now: Gabrielle Siegers
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Summit4CI 2022 – Less than 5 months away!
Mark your calendars! The Summit for Cancer Immunotherapy (Summit4CI), BioCanRx’s sixth scientific conference, is happening this November 19-21, 2022, in the heart of Montréal at Fairmont The Queen Elizabeth Hotel. Join more than 300 scientists, clinicians, research students, economists, industry and patient representatives, along with charity and government groups to discuss the latest advances… Read more »
Bridging a gap in the path to the clinic
It may not be the biggest such facility. But it is, according to Jennifer Quizi, one of the best-kept secrets – in Ottawa, definitely; in Canada, almost certainly; and throughout the world, very likely. It is the Biotherapeutics Manufacturing Centre (BMC), part of The Ottawa Hospital, and a BioCanRx-funded biomanufacturing facility and, for the… Read more »
Where Are They Now: Oliver Varette
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
The BioCanRx Team Celebrates Immunotherapy Month!
Each year, BioCanRx joins the Cancer Research Institute in recognizing and promoting June as Immunotherapy Month to further the goal of a future #Immune2Cancer. This time around, our team decided to join the cause with even more enthusiasm through our involvement in the Cancer Research Institute’s Walk/Run/Move Challenge. Participating BioCanRx staff members have pledged to… Read more »
National Indigenous People’s Day
By Elijah Buffalo National Indigenous Peoples Day is celebrated annually and marks the summer solstice on June 21st. This is an important day to many Indigenous cultures as it is a time to reflect on our place in the universe, to observe and record the relationships we have with community and environment/land, and to… Read more »
Cancer Stakeholder Alliance Member Profile: Catherine Wilhelmy Rech
Member of the Strategic Patient Partner’s committee and coordinating patient-partnerships at Centre Hospitalier Universitaire de Sherbrooke (CRCHUS) & Member of the BioCanRx – Cancer Stakeholder Alliance Working Group – Catherine, could you share with us about your experience with cancer as both a caregiver and patient? As a caregiver, I have been caregiver… Read more »
Come on down and roll the dice!
A look at Let’s Talk Science (LTS) outreach activities offered by the University of Ottawa and Carleton University chapter. LTS helps youth build the skills they need for their – and Canada’s – future success. Through STEM education, LTS helps youth learn to take risks, develop the persistence to find innovative solutions to real-world problems,… Read more »
Introducing the winners of BioCanRx’s 2022 Summer Studentships
BioCanRx is happy to introduce the 16 undergraduate students chosen from across Canada through a competitive application process to be part of our Summer Studentship Program. The program’s goal is to inspire the next generation of highly qualified personnel to pursue research or policy-related work in cancer immuno-oncology. Undergraduate students receive funding to conduct… Read more »
